1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Medical Marijuana Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Medical Marijuana Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Medical Marijuana Market Regional Analysis
6.2 North America Medical Marijuana Market Revenue 2020-2028 (US$ Million)
6.3 North America Medical Marijuana Market Forecast Analysis
7. North America Medical Marijuana Market Analysis – by Product Type
7.1 Dried Form
- 7.1.1 Overview
- 7.1.2 Dried Form: North America Medical Marijuana Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Extract Form
- 7.2.1 Overview
- 7.2.2 Extract Form: North America Medical Marijuana Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. North America Medical Marijuana Market Analysis – by Application
8.1 Pain Management
- 8.1.1 Overview
- 8.1.2 Pain Management: North America Medical Marijuana Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Tourette's
- 8.2.1 Overview
- 8.2.2 Tourette's: North America Medical Marijuana Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.3 Alzheimer's Disease
- 8.3.1 Overview
- 8.3.2 Alzheimer's Disease: North America Medical Marijuana Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.4 Migraines
- 8.4.1 Overview
- 8.4.2 Migraines: North America Medical Marijuana Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.5 Depression and Anxiety
- 8.5.1 Overview
- 8.5.2 Depression and Anxiety: North America Medical Marijuana Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.6 Multiple Sclerosis
- 8.6.1 Overview
- 8.6.2 Multiple Sclerosis: North America Medical Marijuana Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.7 Cancer
- 8.7.1 Overview
- 8.7.2 Cancer: North America Medical Marijuana Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. North America Medical Marijuana Market Analysis – by Distribution Channel
9.1 Retail Pharmacy
- 9.1.1 Overview
- 9.1.2 Retail Pharmacy: North America Medical Marijuana Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 E-Commerce
- 9.2.1 Overview
- 9.2.2 E-Commerce: North America Medical Marijuana Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. North America Medical Marijuana Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Medical Marijuana Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.2.1.1 North America Medical Marijuana Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 US: North America Medical Marijuana Market Breakdown, by Product Type
- 10.2.1.1.2 US: North America Medical Marijuana Market Breakdown, by Application
- 10.2.1.1.3 US: North America Medical Marijuana Market Breakdown, by Distribution Channel
- 10.2.1.2 Canada:
North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Canada: North America Medical Marijuana Market Breakdown, by Product Type
- 10.2.1.2.2 Canada: North America Medical Marijuana Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Medical Marijuana Market Breakdown, by Distribution Channel
- 10.2.1.3 Mexico :
North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Mexico : North America Medical Marijuana Market Breakdown, by Product Type
- 10.2.1.3.2 Mexico : North America Medical Marijuana Market Breakdown, by Application
- 10.2.1.3.3 Mexico : North America Medical Marijuana Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Aphria, Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 CanaQuest Medical Corporation
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Canopy Growth Corporation
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Emerald Health Therapeutics Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 GW Pharmaceuticals
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 MARICANN INC.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Organigram Holdings Inc.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Panaxia Pharmaceutical Industries Ltd.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Phoena Holdings Inc.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 VIVO Cannabis Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations